SEC Form 4 · accession 0001708138-17-000005
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Neil Stahl
Officer — EVP Research and Development
Period of report
Jun 14, 2017
Accepted (ET)
Jun 16, 2017 · 4:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 14, 2017 | M | 20,295 | $21.25 | A | 44,245 | D | |
| Common Stock | Jun 14, 2017 | F | 906 | $475.56 | D | 43,339 | D | |
| Common Stock | Jun 14, 2017 | F | 10,822 | $475.56 | D | 32,517 | D | |
| Common StockF2 | Jun 15, 2017 | S | 500 | $462.72 | D | 32,017 | D | |
| Common Stock | Jun 15, 2017 | S | 100 | $463.91 | D | 31,917 | D | |
| Common StockF3 | Jun 15, 2017 | S | 400 | $464.69 | D | 31,517 | D | |
| Common StockF4 | Jun 15, 2017 | S | 1,244 | $465.49 | D | 30,273 | D | |
| Common StockF5 | Jun 15, 2017 | S | 185 | $466.52 | D | 30,088 | D | |
| Common StockF6 | Jun 15, 2017 | S | 300 | $467.82 | D | 29,788 | D | |
| Common StockF7 | Jun 15, 2017 | S | 900 | $468.63 | D | 28,888 | D | |
| Common StockF8 | Jun 15, 2017 | S | 2,212 | $469.53 | D | 26,676 | D | |
| Common StockF9 | Jun 15, 2017 | S | 2,426 | $470.57 | D | 24,250 | D | |
| Common Stock | Jun 15, 2017 | S | 100 | $471.15 | D | 24,150 | D | |
| Common Stock | Jun 15, 2017 | S | 100 | $472.95 | D | 24,050 | D | |
| Common Stock | Jun 15, 2017 | S | 100 | $474.48 | D | 23,950 | D | |
| Common Stock | holding | — | — | — | 10,000 | I | by GRAT | |
| Common Stock | holding | — | — | — | 5,000 | I | by GRAT | |
| Common Stock | holding | — | — | — | 5,647 | I | By 401(k) Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F10 | $21.25 | Jun 14, 2017 | M | 20,295 | D | — | Dec 18, 2019 | Common Stock | 20,295 | 0 | D |
Explanation of responses
- F1Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- F10The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
- F2Represents volume-weighted average price of sales of 500 shares of Company stock on June 15, 2017 at prices ranging from $462.38 to $462.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 15, 2017 at each separate price.
- F3Represents volume-weighted average price of sales of 400 shares of Company stock on June 15, 2017 at prices ranging from $464.46 to $464.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 15, 2017 at each separate price.
- F4Represents volume-weighted average price of sales of 1,244 shares of Company stock on June 15, 2017 at prices ranging from $465.00 to $465.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 15, 2017 at each separate price.
- F5Represents volume-weighted average price of sales of 185 shares of Company stock on June 15, 2017 at prices ranging from $466.49 to $466.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 15, 2017 at each separate price.
- F6Represents volume-weighted average price of sales of 300 shares of Company stock on June 15, 2017 at prices ranging from $467.70 to $467.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 15, 2017 at each separate price.
- F7Represents volume-weighted average price of sales of 900 shares of Company stock on June 15, 2017 at prices ranging from $468.00 to $468.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 15, 2017 at each separate price.
- F8Represents volume-weighted average price of sales of 2,212 shares of Company stock on June 15, 2017 at prices ranging from $469.07 to $469.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 15, 2017 at each separate price.
- F9Represents volume-weighted average price of sales of 2,426 shares of Company stock on June 15, 2017 at prices ranging from $470.03 to $470.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 15, 2017 at each separate price.